Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Meningioma | 39 | 2024 | 1226 | 6.840 |
Why?
|
Meningeal Neoplasms | 40 | 2024 | 1258 | 6.560 |
Why?
|
Brain Neoplasms | 60 | 2025 | 9213 | 3.560 |
Why?
|
Skull Base Neoplasms | 7 | 2024 | 281 | 2.640 |
Why?
|
Pituitary Neoplasms | 16 | 2024 | 1326 | 2.140 |
Why?
|
Glioma | 24 | 2025 | 3532 | 1.780 |
Why?
|
Radiosurgery | 6 | 2023 | 1346 | 1.510 |
Why?
|
Glioblastoma | 16 | 2024 | 3525 | 1.440 |
Why?
|
Craniopharyngioma | 4 | 2021 | 279 | 1.340 |
Why?
|
Neurosurgical Procedures | 21 | 2024 | 2110 | 1.160 |
Why?
|
Central Nervous System Neoplasms | 5 | 2025 | 930 | 1.000 |
Why?
|
Adenoma | 10 | 2021 | 2164 | 0.940 |
Why?
|
Neuroma, Acoustic | 5 | 2022 | 458 | 0.930 |
Why?
|
Neurosurgery | 4 | 2023 | 690 | 0.910 |
Why?
|
Gliosarcoma | 1 | 2021 | 115 | 0.740 |
Why?
|
Optic Nerve | 1 | 2024 | 571 | 0.700 |
Why?
|
Craniotomy | 6 | 2020 | 747 | 0.700 |
Why?
|
Cranial Nerve Neoplasms | 4 | 2022 | 134 | 0.680 |
Why?
|
Magnetic Resonance Imaging | 34 | 2024 | 36861 | 0.650 |
Why?
|
Neoplasm Recurrence, Local | 20 | 2024 | 9442 | 0.630 |
Why?
|
Isocitrate Dehydrogenase | 9 | 2025 | 958 | 0.610 |
Why?
|
Pituitary Apoplexy | 2 | 2016 | 29 | 0.600 |
Why?
|
Mutation | 32 | 2025 | 30266 | 0.590 |
Why?
|
Clothing | 1 | 2018 | 96 | 0.580 |
Why?
|
DNA Copy Number Variations | 7 | 2017 | 2055 | 0.570 |
Why?
|
Psychophysics | 1 | 2018 | 291 | 0.570 |
Why?
|
Humans | 168 | 2025 | 768887 | 0.540 |
Why?
|
Patient Transfer | 1 | 2023 | 792 | 0.520 |
Why?
|
Elasticity | 1 | 2018 | 657 | 0.520 |
Why?
|
Acromegaly | 2 | 2021 | 316 | 0.510 |
Why?
|
Labyrinth Diseases | 1 | 2017 | 151 | 0.500 |
Why?
|
Skull Base | 5 | 2024 | 294 | 0.500 |
Why?
|
Neurilemmoma | 4 | 2022 | 524 | 0.490 |
Why?
|
Semicircular Canals | 1 | 2017 | 203 | 0.490 |
Why?
|
Cerebellar Neoplasms | 3 | 2015 | 591 | 0.470 |
Why?
|
Chromosomes, Human | 1 | 2016 | 438 | 0.470 |
Why?
|
Prognosis | 25 | 2025 | 30044 | 0.470 |
Why?
|
Motion Perception | 1 | 2018 | 379 | 0.460 |
Why?
|
Cerebral Veins | 1 | 2015 | 159 | 0.440 |
Why?
|
Tomography, Spiral Computed | 1 | 2015 | 274 | 0.430 |
Why?
|
Cerebral Angiography | 2 | 2018 | 1272 | 0.430 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2024 | 8664 | 0.420 |
Why?
|
Histones | 1 | 2023 | 2603 | 0.410 |
Why?
|
Cerebral Arteries | 1 | 2015 | 489 | 0.410 |
Why?
|
Artificial Intelligence | 3 | 2024 | 2665 | 0.400 |
Why?
|
Nervous System Diseases | 2 | 2021 | 1665 | 0.380 |
Why?
|
Cranial Irradiation | 3 | 2023 | 395 | 0.380 |
Why?
|
Methionine | 1 | 2014 | 573 | 0.380 |
Why?
|
Retrospective Studies | 40 | 2025 | 81892 | 0.380 |
Why?
|
Monitoring, Intraoperative | 2 | 2016 | 950 | 0.370 |
Why?
|
Length of Stay | 2 | 2024 | 6525 | 0.370 |
Why?
|
Hospitals | 2 | 2024 | 3903 | 0.360 |
Why?
|
Facial Nerve | 4 | 2023 | 277 | 0.360 |
Why?
|
Hospital Mortality | 1 | 2024 | 5369 | 0.350 |
Why?
|
Necrosis | 3 | 2023 | 1621 | 0.350 |
Why?
|
Preoperative Care | 3 | 2019 | 2258 | 0.340 |
Why?
|
Diffusion Tensor Imaging | 2 | 2024 | 2426 | 0.320 |
Why?
|
Tumor Burden | 6 | 2020 | 1913 | 0.320 |
Why?
|
Diagnostic Imaging | 2 | 2023 | 3538 | 0.320 |
Why?
|
Patient Readmission | 2 | 2020 | 3313 | 0.320 |
Why?
|
Insurance Coverage | 1 | 2020 | 1946 | 0.310 |
Why?
|
Surgery, Computer-Assisted | 2 | 2013 | 1006 | 0.310 |
Why?
|
Genomics | 9 | 2024 | 5928 | 0.300 |
Why?
|
Insurance, Health | 1 | 2020 | 2518 | 0.290 |
Why?
|
Male | 71 | 2025 | 365249 | 0.290 |
Why?
|
Teratoma | 2 | 2015 | 405 | 0.290 |
Why?
|
Adult | 55 | 2025 | 223818 | 0.280 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2023 | 5434 | 0.280 |
Why?
|
Combined Modality Therapy | 11 | 2023 | 8559 | 0.280 |
Why?
|
Hematoma, Subdural, Chronic | 2 | 2020 | 98 | 0.270 |
Why?
|
Ubiquitin Thiolesterase | 3 | 2024 | 465 | 0.270 |
Why?
|
Neuronavigation | 4 | 2024 | 169 | 0.270 |
Why?
|
Middle Aged | 56 | 2025 | 223740 | 0.270 |
Why?
|
Paraneoplastic Polyneuropathy | 1 | 2006 | 2 | 0.270 |
Why?
|
Female | 66 | 2025 | 397464 | 0.260 |
Why?
|
MELAS Syndrome | 1 | 2006 | 56 | 0.260 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13699 | 0.260 |
Why?
|
Astrocytoma | 3 | 2023 | 780 | 0.260 |
Why?
|
Mixed Tumor, Mullerian | 1 | 2006 | 55 | 0.260 |
Why?
|
Adenoma, Oxyphilic | 2 | 2018 | 152 | 0.260 |
Why?
|
Immunotherapy | 6 | 2024 | 4755 | 0.250 |
Why?
|
Hematologic Neoplasms | 1 | 2016 | 1907 | 0.230 |
Why?
|
DNA Mutational Analysis | 9 | 2017 | 4123 | 0.230 |
Why?
|
Neuroendoscopy | 2 | 2016 | 101 | 0.230 |
Why?
|
Rhabdoid Tumor | 2 | 2017 | 211 | 0.230 |
Why?
|
Sella Turcica | 2 | 2015 | 117 | 0.230 |
Why?
|
DNA Methylation | 5 | 2024 | 4432 | 0.230 |
Why?
|
Brain Abscess | 2 | 2015 | 123 | 0.220 |
Why?
|
Radiopharmaceuticals | 1 | 2014 | 2734 | 0.220 |
Why?
|
Aged | 37 | 2025 | 171790 | 0.220 |
Why?
|
Geniculate Bodies | 1 | 2024 | 159 | 0.220 |
Why?
|
Telomerase | 2 | 2021 | 753 | 0.220 |
Why?
|
Hospitalization | 1 | 2023 | 10845 | 0.210 |
Why?
|
Internship and Residency | 1 | 2023 | 5956 | 0.210 |
Why?
|
Epigenesis, Genetic | 2 | 2016 | 3836 | 0.210 |
Why?
|
Ganglia, Spinal | 1 | 2006 | 530 | 0.210 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2021 | 2059 | 0.210 |
Why?
|
Pharmacology | 1 | 2003 | 97 | 0.210 |
Why?
|
Dura Mater | 2 | 2024 | 297 | 0.200 |
Why?
|
Tissue Adhesives | 1 | 2024 | 179 | 0.200 |
Why?
|
Brain | 11 | 2024 | 27476 | 0.200 |
Why?
|
Frozen Sections | 1 | 2002 | 154 | 0.200 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2002 | 424 | 0.200 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2024 | 9081 | 0.190 |
Why?
|
Pituitary Gland | 2 | 2015 | 634 | 0.190 |
Why?
|
Neoplasm Seeding | 2 | 2019 | 85 | 0.190 |
Why?
|
PTEN Phosphohydrolase | 4 | 2021 | 1120 | 0.190 |
Why?
|
Survival Rate | 8 | 2025 | 12873 | 0.180 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13593 | 0.180 |
Why?
|
Prospective Studies | 7 | 2025 | 54950 | 0.180 |
Why?
|
Young Adult | 21 | 2025 | 60110 | 0.180 |
Why?
|
Gene Dosage | 4 | 2017 | 1222 | 0.180 |
Why?
|
Visual Pathways | 1 | 2024 | 559 | 0.170 |
Why?
|
Comparative Genomic Hybridization | 6 | 2017 | 474 | 0.170 |
Why?
|
Treatment Outcome | 20 | 2024 | 65485 | 0.170 |
Why?
|
Neurofibromin 1 | 1 | 2021 | 190 | 0.170 |
Why?
|
RNA Splicing | 1 | 2024 | 905 | 0.170 |
Why?
|
Cerebellopontine Angle | 2 | 2021 | 53 | 0.170 |
Why?
|
Neoadjuvant Therapy | 2 | 2024 | 2909 | 0.170 |
Why?
|
GATA2 Transcription Factor | 1 | 2020 | 158 | 0.170 |
Why?
|
Pneumocephalus | 1 | 2020 | 46 | 0.170 |
Why?
|
Nitric Oxide Synthase | 1 | 2002 | 911 | 0.170 |
Why?
|
Biology | 1 | 2022 | 292 | 0.170 |
Why?
|
Follow-Up Studies | 10 | 2025 | 39394 | 0.170 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2005 | 493 | 0.170 |
Why?
|
Laminectomy | 2 | 2018 | 226 | 0.160 |
Why?
|
Oncolytic Viruses | 1 | 2023 | 345 | 0.160 |
Why?
|
Facial Paralysis | 1 | 2023 | 346 | 0.160 |
Why?
|
Solitary Fibrous Tumors | 1 | 2020 | 70 | 0.160 |
Why?
|
Co-Repressor Proteins | 1 | 2020 | 190 | 0.160 |
Why?
|
Nitriles | 1 | 2024 | 990 | 0.160 |
Why?
|
Pyridones | 1 | 2024 | 819 | 0.160 |
Why?
|
Cranial Sinuses | 1 | 2019 | 68 | 0.160 |
Why?
|
Multilingualism | 1 | 2020 | 88 | 0.160 |
Why?
|
Pneumatosis Cystoides Intestinalis | 1 | 2019 | 31 | 0.160 |
Why?
|
Chromosome Aberrations | 2 | 2016 | 1780 | 0.160 |
Why?
|
Salvage Therapy | 3 | 2019 | 1277 | 0.150 |
Why?
|
Molecular Targeted Therapy | 3 | 2019 | 2830 | 0.150 |
Why?
|
Medical Oncology | 3 | 2025 | 2350 | 0.150 |
Why?
|
Postoperative Complications | 10 | 2023 | 15889 | 0.150 |
Why?
|
Pituitary ACTH Hypersecretion | 1 | 2021 | 180 | 0.150 |
Why?
|
Hydrogels | 1 | 2024 | 745 | 0.150 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 710 | 0.150 |
Why?
|
Collateral Circulation | 1 | 2019 | 291 | 0.150 |
Why?
|
Phlebography | 2 | 2019 | 326 | 0.150 |
Why?
|
Cohort Studies | 10 | 2024 | 41800 | 0.150 |
Why?
|
Herpesvirus 1, Human | 1 | 2023 | 744 | 0.150 |
Why?
|
Interneurons | 1 | 2002 | 593 | 0.150 |
Why?
|
Oncolytic Virotherapy | 1 | 2023 | 521 | 0.150 |
Why?
|
Tumor Microenvironment | 5 | 2023 | 3951 | 0.150 |
Why?
|
Decompression, Surgical | 3 | 2018 | 610 | 0.140 |
Why?
|
Genome, Human | 4 | 2020 | 4456 | 0.140 |
Why?
|
Syringomyelia | 1 | 2018 | 67 | 0.140 |
Why?
|
Tumor Suppressor Proteins | 2 | 2018 | 2813 | 0.140 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2002 | 905 | 0.140 |
Why?
|
Endoscopy | 3 | 2016 | 1862 | 0.140 |
Why?
|
Databases, Factual | 2 | 2024 | 8095 | 0.140 |
Why?
|
Cell Separation | 1 | 2002 | 1728 | 0.140 |
Why?
|
Nerve Tissue Proteins | 3 | 2007 | 4415 | 0.140 |
Why?
|
Uterine Neoplasms | 1 | 2006 | 1424 | 0.140 |
Why?
|
Gonadotrophs | 1 | 2016 | 19 | 0.140 |
Why?
|
Neoplasms, Second Primary | 1 | 2005 | 1060 | 0.140 |
Why?
|
Cell Lineage | 2 | 2017 | 2576 | 0.140 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2018 | 149 | 0.140 |
Why?
|
Brevican | 2 | 2014 | 5 | 0.140 |
Why?
|
Neurofibromatoses | 1 | 2020 | 303 | 0.140 |
Why?
|
Chromogranins | 1 | 2017 | 160 | 0.130 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2021 | 2960 | 0.130 |
Why?
|
Hematoma, Subdural, Acute | 1 | 2016 | 17 | 0.130 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2016 | 43 | 0.130 |
Why?
|
Sphenoid Sinus | 1 | 2016 | 101 | 0.130 |
Why?
|
Arnold-Chiari Malformation | 1 | 2018 | 160 | 0.130 |
Why?
|
Ear Neoplasms | 1 | 2016 | 118 | 0.130 |
Why?
|
World Health Organization | 1 | 2022 | 1327 | 0.130 |
Why?
|
American Civil War | 1 | 2015 | 8 | 0.130 |
Why?
|
Neural Tube Defects | 1 | 2018 | 255 | 0.130 |
Why?
|
Hyponatremia | 1 | 2018 | 279 | 0.130 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 194 | 0.130 |
Why?
|
Ganglioglioma | 1 | 2015 | 36 | 0.130 |
Why?
|
INDEL Mutation | 1 | 2016 | 267 | 0.130 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2018 | 724 | 0.120 |
Why?
|
Endocrine Surgical Procedures | 1 | 2015 | 32 | 0.120 |
Why?
|
Adolescent | 17 | 2025 | 89247 | 0.120 |
Why?
|
Psychosurgery | 1 | 2015 | 86 | 0.120 |
Why?
|
Pinealoma | 1 | 2015 | 52 | 0.120 |
Why?
|
Molecular Chaperones | 1 | 2020 | 763 | 0.120 |
Why?
|
Chordoma | 1 | 2018 | 349 | 0.120 |
Why?
|
Odontoid Process | 1 | 2015 | 46 | 0.120 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2022 | 3671 | 0.120 |
Why?
|
DNA, Neoplasm | 2 | 2017 | 1748 | 0.120 |
Why?
|
Rhizopus | 1 | 2014 | 21 | 0.120 |
Why?
|
Infratentorial Neoplasms | 1 | 2015 | 99 | 0.120 |
Why?
|
Fluorescent Dyes | 1 | 2002 | 1933 | 0.120 |
Why?
|
Pituitary Diseases | 1 | 2015 | 136 | 0.120 |
Why?
|
Vestibule, Labyrinth | 1 | 2016 | 235 | 0.120 |
Why?
|
Famous Persons | 1 | 2015 | 109 | 0.120 |
Why?
|
Medicine | 1 | 2003 | 947 | 0.120 |
Why?
|
Baseball | 1 | 2015 | 95 | 0.110 |
Why?
|
Transcription Factors | 5 | 2024 | 12174 | 0.110 |
Why?
|
Skull Neoplasms | 1 | 2015 | 173 | 0.110 |
Why?
|
Head Protective Devices | 1 | 2015 | 118 | 0.110 |
Why?
|
Endopeptidases | 1 | 2018 | 764 | 0.110 |
Why?
|
Liability, Legal | 1 | 2015 | 209 | 0.110 |
Why?
|
Melanoma | 3 | 2022 | 5709 | 0.110 |
Why?
|
Epidural Space | 1 | 2015 | 123 | 0.110 |
Why?
|
Basal Ganglia Diseases | 1 | 2014 | 145 | 0.110 |
Why?
|
Receptor, erbB-2 | 1 | 2024 | 2606 | 0.110 |
Why?
|
Telomere | 1 | 2020 | 943 | 0.110 |
Why?
|
Gene Expression Profiling | 5 | 2023 | 9549 | 0.110 |
Why?
|
History, 20th Century | 5 | 2022 | 2771 | 0.110 |
Why?
|
Meningitis, Bacterial | 1 | 2016 | 225 | 0.110 |
Why?
|
Angiography, Digital Subtraction | 1 | 2015 | 332 | 0.110 |
Why?
|
Diskectomy | 1 | 2015 | 207 | 0.110 |
Why?
|
Semantics | 1 | 2017 | 618 | 0.110 |
Why?
|
Epidural Abscess | 1 | 2015 | 94 | 0.110 |
Why?
|
Medulla Oblongata | 1 | 2015 | 248 | 0.110 |
Why?
|
Polymerase Chain Reaction | 1 | 2002 | 6085 | 0.110 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2014 | 387 | 0.110 |
Why?
|
Mucormycosis | 1 | 2014 | 102 | 0.110 |
Why?
|
Functional Laterality | 1 | 2020 | 2269 | 0.110 |
Why?
|
Military Personnel | 1 | 2022 | 1264 | 0.110 |
Why?
|
Oligodendroglioma | 1 | 2014 | 278 | 0.100 |
Why?
|
Video Recording | 1 | 2018 | 976 | 0.100 |
Why?
|
Morbidity | 1 | 2018 | 1757 | 0.100 |
Why?
|
Neoplasms | 2 | 2019 | 22390 | 0.100 |
Why?
|
beta Catenin | 1 | 2018 | 1047 | 0.100 |
Why?
|
Hydrocortisone | 1 | 2021 | 1842 | 0.100 |
Why?
|
Ependymoma | 1 | 2016 | 328 | 0.100 |
Why?
|
Radiation Injuries | 1 | 2020 | 1203 | 0.100 |
Why?
|
Microsurgery | 2 | 2015 | 803 | 0.100 |
Why?
|
Venous Thrombosis | 1 | 2022 | 1321 | 0.100 |
Why?
|
Scalp | 1 | 2015 | 391 | 0.100 |
Why?
|
Nuclear Proteins | 4 | 2024 | 5803 | 0.100 |
Why?
|
Aged, 80 and over | 13 | 2020 | 59738 | 0.100 |
Why?
|
Brachytherapy | 1 | 2019 | 1224 | 0.100 |
Why?
|
Social Class | 1 | 2021 | 2009 | 0.100 |
Why?
|
RNA, Messenger | 3 | 2017 | 12809 | 0.100 |
Why?
|
Disease Progression | 8 | 2019 | 13677 | 0.100 |
Why?
|
Regional Blood Flow | 1 | 2015 | 1502 | 0.090 |
Why?
|
Oncogenes | 1 | 2017 | 1236 | 0.090 |
Why?
|
Massachusetts | 1 | 2024 | 8888 | 0.090 |
Why?
|
Postoperative Period | 3 | 2021 | 1830 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2022 | 3518 | 0.090 |
Why?
|
Antibiotic Prophylaxis | 1 | 2016 | 640 | 0.090 |
Why?
|
Malpractice | 1 | 2015 | 561 | 0.090 |
Why?
|
Language | 1 | 2020 | 1559 | 0.090 |
Why?
|
Cell Line, Tumor | 7 | 2022 | 17174 | 0.090 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2017 | 1658 | 0.090 |
Why?
|
Spinal Neoplasms | 1 | 2016 | 715 | 0.090 |
Why?
|
Patient Discharge | 1 | 2023 | 3490 | 0.090 |
Why?
|
Curriculum | 1 | 2023 | 3782 | 0.090 |
Why?
|
Consensus | 3 | 2025 | 3214 | 0.080 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2016 | 617 | 0.080 |
Why?
|
Child | 10 | 2025 | 80969 | 0.080 |
Why?
|
Societies, Medical | 1 | 2022 | 3967 | 0.080 |
Why?
|
Radionuclide Imaging | 1 | 2014 | 1998 | 0.080 |
Why?
|
Neurofibromin 2 | 2 | 2023 | 271 | 0.080 |
Why?
|
SEER Program | 3 | 2022 | 1473 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1494 | 0.080 |
Why?
|
Child, Preschool | 6 | 2024 | 42684 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2019 | 3411 | 0.080 |
Why?
|
Mutation, Missense | 1 | 2018 | 2592 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1880 | 0.080 |
Why?
|
Animals | 14 | 2024 | 169408 | 0.080 |
Why?
|
Brain Diseases | 1 | 2018 | 1558 | 0.080 |
Why?
|
Evolution, Molecular | 1 | 2017 | 1894 | 0.080 |
Why?
|
Algorithms | 3 | 2019 | 14199 | 0.080 |
Why?
|
Pulmonary Embolism | 1 | 2022 | 2598 | 0.080 |
Why?
|
Epilepsy | 1 | 2024 | 3326 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1769 | 0.080 |
Why?
|
Ultrasonography | 2 | 2024 | 6001 | 0.080 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2016 | 957 | 0.070 |
Why?
|
Cerebral Cortex | 2 | 2019 | 5834 | 0.070 |
Why?
|
Clinical Competence | 1 | 2023 | 4859 | 0.070 |
Why?
|
Spine | 1 | 2015 | 1141 | 0.070 |
Why?
|
Seizures | 3 | 2024 | 3000 | 0.070 |
Why?
|
Medicaid | 1 | 2020 | 2843 | 0.070 |
Why?
|
Clinical Trials as Topic | 2 | 2022 | 8055 | 0.070 |
Why?
|
Sequence Analysis, DNA | 4 | 2020 | 4784 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 4 | 2024 | 20776 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2884 | 0.070 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 4926 | 0.070 |
Why?
|
Neoplastic Stem Cells | 1 | 2014 | 1356 | 0.070 |
Why?
|
Health Care Reform | 1 | 2015 | 1262 | 0.070 |
Why?
|
Reproducibility of Results | 5 | 2024 | 20244 | 0.070 |
Why?
|
Genome-Wide Association Study | 2 | 2016 | 12798 | 0.070 |
Why?
|
Recovery of Function | 1 | 2016 | 2990 | 0.060 |
Why?
|
United States | 8 | 2022 | 73180 | 0.060 |
Why?
|
DNA-Binding Proteins | 3 | 2018 | 9618 | 0.060 |
Why?
|
Macrophages | 1 | 2020 | 5800 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2015 | 2848 | 0.060 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2007 | 254 | 0.060 |
Why?
|
Arachnoid Cysts | 1 | 2006 | 60 | 0.060 |
Why?
|
Preoperative Period | 2 | 2018 | 565 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 26384 | 0.060 |
Why?
|
Hemianopsia | 1 | 2006 | 121 | 0.060 |
Why?
|
Remission Induction | 2 | 2021 | 2411 | 0.060 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2006 | 187 | 0.060 |
Why?
|
DNA Helicases | 2 | 2024 | 854 | 0.060 |
Why?
|
Brain Mapping | 1 | 2020 | 6740 | 0.060 |
Why?
|
Ascites | 1 | 2006 | 338 | 0.060 |
Why?
|
Gene Expression | 1 | 2016 | 7602 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 11886 | 0.060 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2019 | 1793 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2022 | 5716 | 0.060 |
Why?
|
Brain Concussion | 1 | 2015 | 1436 | 0.060 |
Why?
|
Basal Ganglia | 1 | 2006 | 555 | 0.060 |
Why?
|
Survivors | 1 | 2014 | 2383 | 0.060 |
Why?
|
Emergency Service, Hospital | 1 | 2023 | 7956 | 0.050 |
Why?
|
Equipment Failure | 1 | 2006 | 585 | 0.050 |
Why?
|
Brain Injuries | 1 | 2015 | 2058 | 0.050 |
Why?
|
Risk Assessment | 1 | 2025 | 24330 | 0.050 |
Why?
|
Receptors, AMPA | 1 | 2024 | 335 | 0.050 |
Why?
|
Korean War | 1 | 2022 | 6 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2017 | 3985 | 0.050 |
Why?
|
History, 19th Century | 2 | 2015 | 715 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2024 | 6131 | 0.050 |
Why?
|
Carbocyanines | 1 | 2002 | 177 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2015 | 2517 | 0.050 |
Why?
|
Rhodamines | 1 | 2002 | 178 | 0.050 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2002 | 175 | 0.050 |
Why?
|
Postoperative Care | 2 | 2019 | 1481 | 0.050 |
Why?
|
Phenotype | 4 | 2024 | 16735 | 0.050 |
Why?
|
Vestibulocochlear Nerve | 1 | 2021 | 115 | 0.050 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2023 | 505 | 0.050 |
Why?
|
Atrophy | 1 | 2006 | 1647 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2021 | 15471 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7460 | 0.050 |
Why?
|
Genetic Testing | 1 | 2014 | 3590 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2018 | 9264 | 0.050 |
Why?
|
Computer Systems | 1 | 2002 | 470 | 0.050 |
Why?
|
Hydrazines | 1 | 2002 | 223 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2020 | 3621 | 0.040 |
Why?
|
Calibration | 1 | 2023 | 823 | 0.040 |
Why?
|
Subdural Space | 1 | 2020 | 38 | 0.040 |
Why?
|
Neoplasm, Residual | 2 | 2016 | 1019 | 0.040 |
Why?
|
ACTH-Secreting Pituitary Adenoma | 1 | 2021 | 64 | 0.040 |
Why?
|
Incidence | 4 | 2022 | 21545 | 0.040 |
Why?
|
Huntington Disease | 1 | 2007 | 1147 | 0.040 |
Why?
|
Sagittal Sinus Thrombosis | 1 | 2019 | 11 | 0.040 |
Why?
|
Age Factors | 3 | 2024 | 18454 | 0.040 |
Why?
|
Lateral Sinus Thrombosis | 1 | 2019 | 7 | 0.040 |
Why?
|
Ultrasonography, Doppler | 1 | 2022 | 463 | 0.040 |
Why?
|
Immunohistochemistry | 3 | 2021 | 11119 | 0.040 |
Why?
|
Reference Standards | 1 | 2023 | 1014 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14751 | 0.040 |
Why?
|
Interleukin-12 | 1 | 2022 | 577 | 0.040 |
Why?
|
Receptors, Progesterone | 1 | 2024 | 1159 | 0.040 |
Why?
|
Reoperation | 3 | 2018 | 4342 | 0.040 |
Why?
|
Arthritis, Rheumatoid | 1 | 2015 | 3780 | 0.040 |
Why?
|
Unemployment | 1 | 2021 | 211 | 0.040 |
Why?
|
Cognition | 1 | 2017 | 7080 | 0.040 |
Why?
|
Pathology, Molecular | 1 | 2022 | 329 | 0.040 |
Why?
|
Genetic Markers | 2 | 2015 | 2604 | 0.040 |
Why?
|
New England | 1 | 2022 | 1058 | 0.040 |
Why?
|
Random Allocation | 1 | 2023 | 2396 | 0.040 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2021 | 619 | 0.040 |
Why?
|
Geography | 1 | 2021 | 654 | 0.040 |
Why?
|
Lasers | 1 | 2002 | 952 | 0.040 |
Why?
|
Syndrome | 1 | 2005 | 3274 | 0.040 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2018 | 146 | 0.040 |
Why?
|
Isoenzymes | 1 | 2002 | 1687 | 0.040 |
Why?
|
Specimen Handling | 1 | 2002 | 708 | 0.040 |
Why?
|
Ecosystem | 1 | 2022 | 494 | 0.040 |
Why?
|
Survival Analysis | 2 | 2023 | 10115 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2017 | 2460 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2020 | 785 | 0.040 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2022 | 633 | 0.040 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2019 | 350 | 0.040 |
Why?
|
Head | 1 | 2023 | 927 | 0.040 |
Why?
|
Signal Transduction | 2 | 2018 | 23652 | 0.040 |
Why?
|
Perioperative Period | 1 | 2019 | 252 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2022 | 4651 | 0.040 |
Why?
|
Face | 1 | 2023 | 1031 | 0.040 |
Why?
|
Pilot Projects | 2 | 2024 | 8742 | 0.040 |
Why?
|
Brain Infarction | 1 | 2019 | 288 | 0.040 |
Why?
|
Cerebellar Diseases | 1 | 2019 | 228 | 0.040 |
Why?
|
Mice | 6 | 2022 | 82074 | 0.030 |
Why?
|
Automation | 1 | 2019 | 589 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2024 | 21187 | 0.030 |
Why?
|
DNA Mismatch Repair | 1 | 2020 | 432 | 0.030 |
Why?
|
Hypophysectomy | 1 | 2016 | 114 | 0.030 |
Why?
|
Mammals | 1 | 2022 | 1136 | 0.030 |
Why?
|
Central Nervous System | 1 | 2024 | 1345 | 0.030 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2019 | 640 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2020 | 2018 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2006 | 3782 | 0.030 |
Why?
|
Corpus Striatum | 1 | 2002 | 1237 | 0.030 |
Why?
|
Limit of Detection | 1 | 2017 | 277 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2020 | 618 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1229 | 0.030 |
Why?
|
Cell Tracking | 1 | 2017 | 140 | 0.030 |
Why?
|
History, 21st Century | 1 | 2022 | 1575 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 615 | 0.030 |
Why?
|
Verbal Behavior | 1 | 2017 | 336 | 0.030 |
Why?
|
Mental Disorders | 1 | 2015 | 6879 | 0.030 |
Why?
|
Cranial Nerve Injuries | 1 | 2015 | 28 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5864 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2020 | 1866 | 0.030 |
Why?
|
Medically Uninsured | 1 | 2021 | 841 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2016 | 513 | 0.030 |
Why?
|
Head Injuries, Penetrating | 1 | 2015 | 28 | 0.030 |
Why?
|
Rats | 3 | 2014 | 23847 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2357 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2020 | 1231 | 0.030 |
Why?
|
Risk Factors | 5 | 2022 | 74971 | 0.030 |
Why?
|
Sphenoid Bone | 1 | 2016 | 177 | 0.030 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2016 | 303 | 0.030 |
Why?
|
Cadaver | 1 | 2019 | 1366 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2024 | 1924 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 3 | 2018 | 18065 | 0.030 |
Why?
|
Health Resources | 1 | 2021 | 951 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2006 | 2831 | 0.030 |
Why?
|
Trigeminal Nerve Diseases | 1 | 2015 | 48 | 0.030 |
Why?
|
Follicle Stimulating Hormone | 1 | 2016 | 727 | 0.030 |
Why?
|
Pineal Gland | 1 | 2015 | 158 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1105 | 0.030 |
Why?
|
Biopsy | 2 | 2017 | 6805 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 2 | 2019 | 4077 | 0.030 |
Why?
|
Cell Survival | 2 | 2014 | 5794 | 0.030 |
Why?
|
Pons | 1 | 2015 | 242 | 0.030 |
Why?
|
Disease Management | 1 | 2025 | 2537 | 0.030 |
Why?
|
Swine | 1 | 2024 | 5998 | 0.030 |
Why?
|
RNA, Neoplasm | 1 | 2016 | 751 | 0.030 |
Why?
|
Retina | 1 | 2024 | 2661 | 0.030 |
Why?
|
Gene Fusion | 1 | 2016 | 357 | 0.030 |
Why?
|
Therapeutic Irrigation | 1 | 2015 | 297 | 0.030 |
Why?
|
Clone Cells | 1 | 2017 | 1670 | 0.030 |
Why?
|
Educational Status | 1 | 2021 | 2515 | 0.030 |
Why?
|
Steroids | 1 | 2018 | 938 | 0.030 |
Why?
|
Treatment Failure | 1 | 2019 | 2663 | 0.030 |
Why?
|
Brain Stem Neoplasms | 1 | 2015 | 191 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3625 | 0.030 |
Why?
|
Wakefulness | 1 | 2020 | 1284 | 0.030 |
Why?
|
Observer Variation | 1 | 2019 | 2623 | 0.030 |
Why?
|
Leadership | 1 | 2022 | 1396 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2024 | 3450 | 0.030 |
Why?
|
Rats, Inbred Lew | 1 | 2014 | 1163 | 0.030 |
Why?
|
Surgical Instruments | 1 | 2015 | 385 | 0.030 |
Why?
|
Homicide | 1 | 2015 | 294 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2018 | 904 | 0.030 |
Why?
|
Income | 1 | 2021 | 1878 | 0.020 |
Why?
|
Neurologic Examination | 1 | 2015 | 916 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2019 | 1434 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2005 | 4940 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2016 | 1839 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2018 | 10486 | 0.020 |
Why?
|
Area Under Curve | 1 | 2016 | 1645 | 0.020 |
Why?
|
Mice, Nude | 1 | 2018 | 3631 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2002 | 8200 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 906 | 0.020 |
Why?
|
Mice, SCID | 1 | 2016 | 2631 | 0.020 |
Why?
|
Serine Endopeptidases | 1 | 2016 | 1027 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2020 | 2323 | 0.020 |
Why?
|
Nose | 1 | 2015 | 523 | 0.020 |
Why?
|
Hearing | 1 | 2015 | 505 | 0.020 |
Why?
|
Genotype | 2 | 2016 | 13048 | 0.020 |
Why?
|
Cerebrovascular Disorders | 1 | 2018 | 1486 | 0.020 |
Why?
|
Infant | 3 | 2018 | 36541 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2015 | 1390 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2981 | 0.020 |
Why?
|
Down-Regulation | 1 | 2017 | 2941 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2018 | 3629 | 0.020 |
Why?
|
Drainage | 1 | 2015 | 1184 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2013 | 1585 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 13020 | 0.020 |
Why?
|
Visual Fields | 1 | 2016 | 1067 | 0.020 |
Why?
|
Intracranial Hemorrhages | 1 | 2015 | 811 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2014 | 1836 | 0.020 |
Why?
|
Autophagy | 1 | 2017 | 1351 | 0.020 |
Why?
|
Wounds, Gunshot | 1 | 2015 | 588 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2021 | 2593 | 0.020 |
Why?
|
Poverty | 1 | 2021 | 2720 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2022 | 3626 | 0.020 |
Why?
|
Gene Silencing | 1 | 2015 | 1505 | 0.020 |
Why?
|
Exons | 1 | 2014 | 2395 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2016 | 2041 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2017 | 1887 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2017 | 2063 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8512 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6546 | 0.020 |
Why?
|
Time Factors | 2 | 2016 | 40266 | 0.020 |
Why?
|
Cerebellum | 1 | 2015 | 1522 | 0.020 |
Why?
|
Temporal Lobe | 1 | 2015 | 1728 | 0.020 |
Why?
|
Phosphorylation | 1 | 2018 | 8317 | 0.020 |
Why?
|
Memory | 1 | 2017 | 2210 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7860 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2016 | 7472 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3554 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2014 | 1739 | 0.020 |
Why?
|
Attention | 1 | 2017 | 2425 | 0.020 |
Why?
|
Anticoagulants | 1 | 2022 | 4850 | 0.020 |
Why?
|
Cell Movement | 1 | 2018 | 5216 | 0.020 |
Why?
|
Mice, Inbred DBA | 1 | 2007 | 624 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10276 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6856 | 0.020 |
Why?
|
Twins, Monozygotic | 1 | 2007 | 472 | 0.020 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2005 | 142 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3433 | 0.020 |
Why?
|
Diseases in Twins | 1 | 2007 | 447 | 0.020 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 2006 | 197 | 0.010 |
Why?
|
Ventriculostomy | 1 | 2006 | 132 | 0.010 |
Why?
|
Computational Biology | 1 | 2016 | 3562 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2015 | 5801 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14795 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2007 | 2299 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3856 | 0.010 |
Why?
|
Genomic Instability | 1 | 2007 | 715 | 0.010 |
Why?
|
DNA Primers | 1 | 2007 | 2827 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2017 | 3238 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9375 | 0.010 |
Why?
|
Critical Care | 1 | 2015 | 2715 | 0.010 |
Why?
|
Glycosylation | 1 | 2005 | 1101 | 0.010 |
Why?
|
Lectins, C-Type | 1 | 2005 | 593 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5342 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22381 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2006 | 1195 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12563 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2005 | 1714 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11262 | 0.010 |
Why?
|
Heart Atria | 1 | 2006 | 1360 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2015 | 4064 | 0.010 |
Why?
|
Visual Cortex | 1 | 2007 | 1112 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10397 | 0.010 |
Why?
|
Pediatrics | 1 | 2014 | 3628 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2018 | 26394 | 0.010 |
Why?
|
Apoptosis | 1 | 2014 | 9528 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 16051 | 0.010 |
Why?
|
Transfection | 1 | 2005 | 5763 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2014 | 11684 | 0.010 |
Why?
|
Base Sequence | 1 | 2007 | 12430 | 0.010 |
Why?
|
Cell Membrane | 1 | 2005 | 3659 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2007 | 9564 | 0.010 |
Why?
|
Neurons | 1 | 2007 | 9524 | 0.000 |
Why?
|